Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 2/20 | 0.39 |
| ▸ | SLC33A1 | O00400 | 2/20 | 0.38 |
| ▸ | KCNJ6 | P48051 | 1/20 | 0.35 |
| ▸ | KCNJ5 | P48544 | 1/20 | 0.35 |
| ▸ | KCNJ3 | P48549 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.34 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.33 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.33 |
| ▸ | GCGR | P47871 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9738441 | 0.95 | RIPK1 (0.39) | RIPK1SLC33A1KCNJ6KCNJ5KCNJ3 | |
| SCHEMBL9739551 | 0.94 | RIPK1 (0.42) | RIPK1SLC33A1KCNJ6KCNJ5KCNJ3 | |
| SCHEMBL9739920 | 0.91 | RIPK1 (0.42) | RIPK1SLC33A1KCNJ6KCNJ5KCNJ3 | |
| SCHEMBL9740299 | 0.90 | RIPK1 (0.42) | RIPK1SLC33A1KCNJ6KCNJ5KCNJ3 | |
| SCHEMBL9738648 | 0.90 | RIPK1 (0.42) | RIPK1SLC33A1KCNJ6KCNJ5KCNJ3 | |
| SCHEMBL9738242 | 0.89 | RIPK1 (0.40) | RIPK1SLC33A1KCNJ6KCNJ5KCNJ3 | |
| SCHEMBL9552902 | 0.88 | SLC33A1 (0.40) | RIPK1SLC33A1KCNJ6KCNJ5KCNJ3 | |
| SCHEMBL9552858 | 0.88 | SLC33A1 (0.39) | RIPK1SLC33A1KCNJ6KCNJ5KCNJ3 | |
| SCHEMBL9738537 | 0.87 | RIPK1 (0.42) | RIPK1SLC33A1KCNJ6KCNJ5KCNJ3 | |
| SCHEMBL9553447 | 0.87 | SLC33A1 (0.39) | RIPK1SLC33A1TRPV1AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992005161-A1 | 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1992-04-02 | — | — | WO | claimed |
| WO-1992005161-A1 | 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS | G.D. SEARLE & CO. (US) | 1992-04-02 | — | — | WO | disclosed |